Logal Adam
Known title: Sr. Vice President, CFOCIK: 0001356197
Associated companies
Transaction History
| OPK | ▼ Sell | Tax Withholding | 53,266 | $65K | 7/24/2026 | View on chart |
| OPK | ▲ Buy | Grant | 437,500 | $0 | 7/24/2024 | View on chart |
| OPK | ▼ Sell | Tax Withholding | 53,266 | $65K | 7/24/2026 | View on chart |
| OPK | ▲ Buy | Grant | 437,500 | $0 | 7/24/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
OPKO Health Shares Rise on $722M BioReference Asset Sale
OPKO Health announced it sold BioReference laboratory assets to Labcorp for $722 million, a key part of Labcorp’s up to $872 million acquisition. The transaction was reflected in a sharp increase in OPKO’s stock price. The deal highlights OPKO’s focus on divesting non‑core assets. The move follows Labcorp’s broader strategy to expand its laboratory services.
OPKO Health Shares Rise on $722M BioReference Asset Sale. OPKO Health announced it sold BioReference laboratory assets to Labcorp for $722 million, a key part of Labcorp’s up to $872 million acquisition. The transaction was reflected in a sharp increase in OPKO’s stock price. The deal highlights OPKO’s focus on divesting non‑core assets. The move follows Labcorp’s broader strategy to expand its laboratory services.